Q1 2019

Filed May 7, 2019 · 10-Q · 37 days after period end · 0001104506-19-000014

Q1 2019 · 10-Q

Revenue

$21.90M

— vs Q1 2018

Net Income

-$74.15M

N/M vs Q1 2018

EPS Diluted

-$0.96

N/M vs Q1 2018

Gross Profit$17,752,000—

Operating Income

Same quarter

Metric	Q1 2019	Q1 2018	Q1 2017	Q1 2016
Revenue	$21.90M	$0.00	$0.00	$0.00
Net Income	-$74.15M	-$68.52M	-$37.41M	-$33.53M
EPS Diluted	-$0.96	-$0.89	-$0.60	-$0.54

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR